CN113881074A - Preparation method of thin polyurethane medical gloves - Google Patents

Preparation method of thin polyurethane medical gloves Download PDF

Info

Publication number
CN113881074A
CN113881074A CN202111361942.9A CN202111361942A CN113881074A CN 113881074 A CN113881074 A CN 113881074A CN 202111361942 A CN202111361942 A CN 202111361942A CN 113881074 A CN113881074 A CN 113881074A
Authority
CN
China
Prior art keywords
deionized water
stirring
parts
solution
composite material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111361942.9A
Other languages
Chinese (zh)
Inventor
张伯侯
朱江
夏杰
刘海
方磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Hokai Medical Supplies Technology Co ltd
Original Assignee
Anhui Hokai Medical Supplies Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Hokai Medical Supplies Technology Co ltd filed Critical Anhui Hokai Medical Supplies Technology Co ltd
Priority to CN202111361942.9A priority Critical patent/CN113881074A/en
Publication of CN113881074A publication Critical patent/CN113881074A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/02Direct processing of dispersions, e.g. latex, to articles
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D19/00Gloves
    • A41D19/0055Plastic or rubber gloves
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2375/00Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
    • C08J2375/04Polyurethanes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/02Elements
    • C08K3/08Metals
    • C08K2003/0806Silver
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K2201/00Specific properties of additives
    • C08K2201/011Nanostructured additives
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00Use of pretreated ingredients
    • C08K9/12Adsorbed ingredients, e.g. ingredients on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to a preparation method of thin polyurethane medical gloves, which comprises the following raw materials in parts by weight: 15-35 parts of antibacterial composite material, 20-50 parts of polyurethane emulsion, 10-15 parts of surfactant and 20-80 parts of deionized water; adding a surfactant into the polyurethane emulsion, heating to 35-45 ℃, adding an antibacterial composite material, slowly adding deionized water, keeping the temperature, mixing and stirring for 3 hours to obtain a mixed emulsion; dipping the mould in the mixed emulsion for 1min, taking out, drying, curling and demoulding to obtain the medical gloves; the nano microspheres are combined with the initial material in the preparation process of the antibacterial composite material, the nano microspheres with antibacterial property are loaded due to the high porosity and high specific surface area of the antibacterial composite material, and the phenomenon of uneven distribution caused by agglomeration of the nano microspheres is prevented.

Description

Preparation method of thin polyurethane medical gloves
Technical Field
The invention belongs to the technical field of high polymer materials, and particularly relates to a preparation method of thin polyurethane medical gloves.
Background
At present, in a plurality of industries such as medical care, food health care, electronics and the like, the requirements on the protective performance of gloves are higher and higher, the traditional gloves only comprise natural latex gloves, polyvinyl chloride gloves, butyronitrile gloves, polyethylene gloves and the like, wherein the polyethylene gloves have no elasticity and are small in use field, the strength and the elasticity of the polyvinyl chloride gloves are slightly good, the gloves are suitable for simple hand protection, the gloves with the best elasticity only comprise the natural latex gloves and the butyronitrile gloves, and the butyronitrile gloves do not contain protein in the natural latex gloves, so that the wearing glove allergy can not be caused, and the gloves gradually replace the natural latex gloves. But the butyronitrile gloves with the best comprehensive performance are limited in use due to the defects of sulfur, easy breakage and the like. At present, most medical gloves such as natural latex gloves and butyronitrile gloves contain double bond groups, so that a radiation disinfection method cannot be adopted, otherwise, the gloves are easy to age, and therefore, the medical gloves with excellent antibacterial performance are produced, and the medical gloves have excellent mechanical performance and are problems to be solved urgently.
Disclosure of Invention
In order to solve the technical problems, the invention provides a preparation method of thin polyurethane medical gloves.
The purpose of the invention can be realized by the following technical scheme:
a preparation method of a thin polyurethane medical glove comprises the following steps:
step S1, weighing the following raw materials in parts by weight: 15-35 parts of antibacterial composite material, 20-50 parts of polyurethane emulsion, 10-15 parts of surfactant and 20-80 parts of deionized water;
step S2, adding a surfactant into the polyurethane emulsion, heating to 35-45 ℃, adding the antibacterial composite material, slowly adding deionized water, keeping the temperature, mixing and stirring for 3 hours to obtain mixed emulsion;
and step S3, dipping the mold in the mixed emulsion for 1min, taking out, drying, curling and demolding to obtain the medical glove.
Further: the antibacterial composite material is prepared by the following steps:
step S11, adding calcium nitrate tetrahydrate into deionized water, stirring at a constant speed until the calcium nitrate tetrahydrate is dissolved to prepare a solution a for later use, and controlling the dosage ratio of the calcium nitrate tetrahydrate to the deionized water to be 230 g: 1000 mL; adding sodium phosphate dodecahydrate into deionized water, stirring at a constant speed until the sodium phosphate dodecahydrate is dissolved to prepare a solution b for later use, and controlling the dosage ratio of the sodium phosphate dodecahydrate to the deionized water to be 225 g: 1500 mL;
step S12, slowly dripping the solution a into the solution b, heating at 45-60 ℃, stirring at a constant speed, adjusting the pH value of the system to 10-12 after finishing dripping, carrying out ultrasonic treatment and stirring at a constant speed for 1h, continuing stirring for 20h after finishing ultrasonic treatment, then filtering, washing with deionized water until the system is neutral to prepare a primary material, and controlling the volume ratio of the solution a to the solution b to be 1: 1.5;
step S13, adding glycidyl methacrylate into a flask filled with deionized water, vacuumizing, introducing nitrogen, heating to 65-70 ℃, uniformly stirring, adding potassium persulfate, keeping the temperature and reacting for 8 hours, cooling to room temperature, adding anhydrous ethylenediamine, heating to 80 ℃, keeping the temperature and reacting for 20 hours to obtain a crude product, washing the crude product with anhydrous ethanol and deionized water for three times respectively to obtain a carrier, controlling the volume ratio of the glycidyl methacrylate to the deionized water to be 1: 20, wherein the usage amount of the anhydrous ethylenediamine is three times of the volume of the glycidyl methacrylate, and the usage amount of the potassium persulfate is 1-1.8% of the weight of the glycidyl methacrylate;
step S14, adding the carrier into deionized water, stirring at a constant speed for 15min, then sequentially adding a silver nitrate solution with the mass fraction of 20%, heating at 125 ℃, continuing to stir for 5min, adding polyvinylpyrrolidone and absolute ethyl alcohol, stirring at a constant speed for 30min, transferring to a sterilization pot, preserving heat and sterilizing at 0.25MPa and 130 ℃ for 1h, then cooling, adding the primary material, stirring at a high speed for 4h, and then cleaning with absolute ethyl alcohol for 3 times to obtain the antibacterial composite material, wherein the dosage ratio of the carrier, the silver nitrate solution, the polyvinylpyrrolidone, the absolute ethyl alcohol, the deionized water and the primary material is controlled to be 10 g: 1-2.5 g: 3 mL: 10 mL: 35-50 g.
Step S2, mixing the two solutions, reacting calcium nitrate with sodium phosphate under ultrasonic condition to generate hydroxyapatite, namely a primary material, the primary material has larger pores, then in step S3, the glycidyl methacrylate is taken as a monomer, the potassium persulfate is taken as an initiator, the ethylenediamine is added, the glycidyl methacrylate reacts with the ethylenediamine to prepare a carrier, the carrier is an aminated nano microsphere, nano silver is loaded in the carrier through a hydrothermal synthesis method in step S14 to form the nano microsphere with excellent antibacterial property, then a primary material is added to combine the nano microsphere and the primary material, the high porosity and the high specific surface area endow the nano-microsphere with excellent adsorption performance, and the nano-microsphere with antibacterial performance is loaded to prevent the phenomenon of uneven distribution caused by agglomeration.
Further: the surfactant is any one of sodium dodecyl sulfate and sodium dodecyl sulfate.
Further: the drying temperature in the step S3 is 90-100 ℃, and the drying time is 4 h.
The invention has the beneficial effects that:
the invention relates to a polyurethane medical glove, which takes polyurethane emulsion as a base material, adds an antibacterial composite material to endow the polyurethane medical glove with excellent antibacterial performance, the antibacterial composite material is prepared by mixing two solutions in step S2 in the preparation process, calcium nitrate reacts with sodium phosphate under the ultrasonic condition to generate hydroxyapatite which is a primary material, the primary material has larger pores, then glycidyl methacrylate is taken as a monomer in step S3, potassium persulfate is taken as an initiator, ethylenediamine is added, the glycidyl methacrylate reacts with ethylenediamine to prepare a carrier, the carrier is an aminated nano microsphere, then nano silver is loaded in the carrier in step S14 through a hydrothermal synthesis method to form the nano microsphere with excellent antibacterial performance, the technical problems that the nano silver is not easy to disperse and is not easy to attach to a substrate are solved, then the primary material is added, the nano microspheres are combined with the primary material, the nano microspheres with antibacterial property are loaded due to the excellent adsorption property of the primary material, and the phenomenon of uneven distribution caused by agglomeration of the nano microspheres is prevented.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The antibacterial composite material is prepared by the following steps:
step S11, adding calcium nitrate tetrahydrate into deionized water, stirring at a constant speed until the calcium nitrate tetrahydrate is dissolved to prepare a solution a for later use, and controlling the dosage ratio of the calcium nitrate tetrahydrate to the deionized water to be 230 g: 1000 mL; adding sodium phosphate dodecahydrate into deionized water, stirring at a constant speed until the sodium phosphate dodecahydrate is dissolved to prepare a solution b for later use, and controlling the dosage ratio of the sodium phosphate dodecahydrate to the deionized water to be 225 g: 1500 mL;
step S12, slowly dripping the solution a into the solution b, heating at 45 ℃, uniformly stirring, adjusting the pH value of the system to 10 after finishing dripping, carrying out ultrasonic treatment and uniformly stirring for 1h, continuously stirring for 20h after finishing ultrasonic treatment, then filtering, washing with deionized water until the system is neutral to prepare a primary material, and controlling the volume ratio of the solution a to the solution b to be 1: 1.5;
step S13, adding glycidyl methacrylate into a flask filled with deionized water, vacuumizing, introducing nitrogen, heating to 65 ℃, uniformly stirring, adding potassium persulfate, preserving heat, reacting for 8 hours, cooling to room temperature, adding anhydrous ethylenediamine, heating to 80 ℃, preserving heat, reacting for 20 hours to obtain a crude product, washing with anhydrous ethanol and deionized water for three times respectively to obtain a carrier, controlling the volume ratio of the glycidyl methacrylate to the deionized water to be 1: 20, wherein the usage amount of the anhydrous ethylenediamine is three times of the volume of the glycidyl methacrylate, and the usage amount of the potassium persulfate is 1% of the weight of the glycidyl methacrylate;
step S14, adding the carrier into deionized water, stirring at a constant speed for 15min, then sequentially adding a silver nitrate solution with the mass fraction of 20%, heating at 125 ℃, continuing to stir for 5min, adding polyvinylpyrrolidone and absolute ethyl alcohol, stirring at a constant speed for 30min, transferring to a sterilization pot, preserving heat and sterilizing at 0.25MPa and 130 ℃ for 1h, then cooling, adding the primary material, stirring at a high speed for 4h, and then cleaning with absolute ethyl alcohol for 3 times to obtain the antibacterial composite material, wherein the dosage ratio of the carrier, the silver nitrate solution, the polyvinylpyrrolidone, the absolute ethyl alcohol, the deionized water and the primary material is controlled to be 10 g: 1 g: 3 mL: 10 mL: 35 g.
Through detection, the bacteriostasis rate of the antibacterial agent in the embodiment 1 to escherichia coli is 99.7-99.9%, and the bacteriostasis rate to staphylococcus aureus is 99.3-99.6%.
Example 2
The antibacterial composite material is prepared by the following steps:
step S11, adding calcium nitrate tetrahydrate into deionized water, stirring at a constant speed until the calcium nitrate tetrahydrate is dissolved to prepare a solution a for later use, and controlling the dosage ratio of the calcium nitrate tetrahydrate to the deionized water to be 230 g: 1000 mL; adding sodium phosphate dodecahydrate into deionized water, stirring at a constant speed until the sodium phosphate dodecahydrate is dissolved to prepare a solution b for later use, and controlling the dosage ratio of the sodium phosphate dodecahydrate to the deionized water to be 225 g: 1500 mL;
step S12, slowly dripping the solution a into the solution b, heating at 50 ℃, uniformly stirring, adjusting the pH value of the system to 11 after finishing dripping, carrying out ultrasonic treatment and uniformly stirring for 1h, continuously stirring for 20h after finishing ultrasonic treatment, then filtering, washing with deionized water until the system is neutral to prepare a primary material, and controlling the volume ratio of the solution a to the solution b to be 1: 1.5;
step S13, adding glycidyl methacrylate into a flask filled with deionized water, vacuumizing, introducing nitrogen, heating to 65 ℃, uniformly stirring, adding potassium persulfate, preserving heat, reacting for 8 hours, cooling to room temperature, adding anhydrous ethylenediamine, heating to 80 ℃, preserving heat, reacting for 20 hours to obtain a crude product, washing with anhydrous ethanol and deionized water for three times respectively to obtain a carrier, controlling the volume ratio of the glycidyl methacrylate to the deionized water to be 1: 20, wherein the usage amount of the anhydrous ethylenediamine is three times of the volume of the glycidyl methacrylate, and the usage amount of the potassium persulfate is 1.5% of the weight of the glycidyl methacrylate;
step S14, adding the carrier into deionized water, stirring at a constant speed for 15min, then sequentially adding a silver nitrate solution with the mass fraction of 20%, heating at 125 ℃, continuing to stir for 5min, adding polyvinylpyrrolidone and absolute ethyl alcohol, stirring at a constant speed for 30min, transferring to a sterilization pot, preserving heat and sterilizing at 0.25MPa and 130 ℃ for 1h, then cooling, adding the primary material, stirring at a high speed for 4h, and then cleaning with absolute ethyl alcohol for 3 times to obtain the antibacterial composite material, wherein the dosage ratio of the carrier, the silver nitrate solution, the polyvinylpyrrolidone, the absolute ethyl alcohol, the deionized water and the primary material is controlled to be 10 g: 2 g: 3 mL: 10 mL: 40 g.
Through detection, the bacteriostasis rate of the antibacterial agent in the embodiment 2 to escherichia coli is 99.8-99.9%, and the bacteriostasis rate to staphylococcus aureus is 99.3-99.5%.
Example 3
The antibacterial composite material is prepared by the following steps:
step S11, adding calcium nitrate tetrahydrate into deionized water, stirring at a constant speed until the calcium nitrate tetrahydrate is dissolved to prepare a solution a for later use, and controlling the dosage ratio of the calcium nitrate tetrahydrate to the deionized water to be 230 g: 1000 mL; adding sodium phosphate dodecahydrate into deionized water, stirring at a constant speed until the sodium phosphate dodecahydrate is dissolved to prepare a solution b for later use, and controlling the dosage ratio of the sodium phosphate dodecahydrate to the deionized water to be 225 g: 1500 mL;
step S12, slowly dripping the solution a into the solution b, heating at 60 ℃, uniformly stirring, adjusting the pH value of the system to 12 after finishing dripping, carrying out ultrasonic treatment and uniformly stirring for 1h, continuously stirring for 20h after finishing ultrasonic treatment, then filtering, washing with deionized water until the system is neutral to prepare a primary material, and controlling the volume ratio of the solution a to the solution b to be 1: 1.5;
step S13, adding glycidyl methacrylate into a flask filled with deionized water, vacuumizing, introducing nitrogen, heating to 70 ℃, uniformly stirring, adding potassium persulfate, preserving heat and reacting for 8 hours, cooling to room temperature, adding anhydrous ethylenediamine, heating to 80 ℃, preserving heat and reacting for 20 hours to obtain a crude product, washing with anhydrous ethanol and deionized water for three times respectively to obtain a carrier, controlling the volume ratio of the glycidyl methacrylate to the deionized water to be 1: 20, wherein the usage amount of the anhydrous ethylenediamine is three times of the volume of the glycidyl methacrylate, and the usage amount of the potassium persulfate is 1.8% of the weight of the glycidyl methacrylate;
step S14, adding the carrier into deionized water, stirring at a constant speed for 15min, then sequentially adding a silver nitrate solution with the mass fraction of 20%, heating at 125 ℃, continuing to stir for 5min, adding polyvinylpyrrolidone and absolute ethyl alcohol, stirring at a constant speed for 30min, transferring to a sterilization pot, preserving heat and sterilizing at 0.25MPa and 130 ℃ for 1h, then cooling, adding the primary material, stirring at a high speed for 4h, and then cleaning with absolute ethyl alcohol for 3 times to obtain the antibacterial composite material, wherein the dosage ratio of the carrier, the silver nitrate solution, the polyvinylpyrrolidone, the absolute ethyl alcohol, the deionized water and the primary material is controlled to be 10 g: 2.5 g: 3 mL: 10 mL: 50 g.
Through detection, the bacteriostasis rate of the antibacterial agent in example 3 to escherichia coli is 99.7-99.8%, and the bacteriostasis rate to staphylococcus aureus is 99.5-99.6%.
Example 4
A preparation method of a thin polyurethane medical glove comprises the following steps:
step S1, weighing the following raw materials in parts by weight: 15 parts of an antibacterial composite material, 20 parts of AH-1720A polyurethane emulsion produced by the company Anda Huatai, 10 parts of sodium dodecyl sulfate and 20 parts of deionized water;
step S2, adding sodium dodecyl sulfate into polyurethane emulsion, heating to 35 ℃, adding an antibacterial composite material, slowly adding deionized water, keeping the temperature, mixing and stirring for 3 hours to obtain mixed emulsion;
and step S3, dipping the mold in the mixed emulsion for 1min, taking out, drying, curling and demolding to obtain the medical glove.
Example 5
A preparation method of a thin polyurethane medical glove comprises the following steps:
step S1, weighing the following raw materials in parts by weight: 25 parts of an antibacterial composite material, 35 parts of AH-1720A polyurethane emulsion produced by the company Anda Huatai, 12 parts of sodium dodecyl sulfate and 60 parts of deionized water;
step S2, adding sodium dodecyl sulfate into polyurethane emulsion, heating to 40 ℃, adding an antibacterial composite material, slowly adding deionized water, keeping the temperature, mixing and stirring for 3 hours to obtain mixed emulsion;
and step S3, dipping the mold in the mixed emulsion for 1min, taking out, drying, curling and demolding to obtain the medical glove.
Example 6
A preparation method of a thin polyurethane medical glove comprises the following steps:
step S1, weighing the following raw materials in parts by weight: 35 parts of an antibacterial composite material, 50 parts of AH-1720A polyurethane emulsion produced by the company Anda Huatai, 15 parts of sodium dodecyl sulfate and 80 parts of deionized water;
step S2, adding sodium dodecyl sulfate into polyurethane emulsion, heating to 45 ℃, adding an antibacterial composite material, slowly adding deionized water, keeping the temperature, mixing and stirring for 3 hours to obtain mixed emulsion;
and step S3, dipping the mold in the mixed emulsion for 1min, taking out, drying, curling and demolding to obtain the medical glove.
Comparative example 1
In comparison with example 4, the present comparative example did not include the antimicrobial composite.
Comparative example 2
This comparative example is a commercially available polyurethane medical glove from a company.
The mechanical properties of the medical gloves prepared in examples 4-6 and comparative examples 1-2 were measured by the test method of GB/T1701-2001, and the results are shown in the following table:
Figure BDA0003359616400000081
from the above table, it can be seen that the mechanical properties of the antibacterial composite materials added in examples 4-6 are not affected.
In the description herein, references to the description of "one embodiment," "an example," "a specific example" or the like are intended to mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
The foregoing is illustrative and explanatory only and is not intended to be exhaustive or to limit the invention to the precise embodiments described, and various modifications, additions, and substitutions may be made by those skilled in the art without departing from the scope of the invention or exceeding the scope of the claims.

Claims (7)

1. A preparation method of thin polyurethane medical gloves is characterized in that: the method comprises the following steps:
step S1, weighing the following raw materials in parts by weight: 15-35 parts of antibacterial composite material, 20-50 parts of polyurethane emulsion, 10-15 parts of surfactant and 20-80 parts of deionized water;
step S2, adding a surfactant into the polyurethane emulsion, heating to 35-45 ℃, adding the antibacterial composite material, slowly adding deionized water, keeping the temperature, mixing and stirring for 3 hours to obtain mixed emulsion;
and step S3, dipping the mold in the mixed emulsion for 1min, taking out, drying, curling and demolding to obtain the medical glove.
2. The method of manufacturing a thin polyurethane medical glove according to claim 1, wherein: the antibacterial composite material is prepared by the following steps:
step S11, adding calcium nitrate tetrahydrate into deionized water, stirring at a constant speed until the calcium nitrate tetrahydrate is dissolved to prepare a solution a for later use, and controlling the dosage ratio of the calcium nitrate tetrahydrate to the deionized water to be 230 g: 1000 mL; adding sodium phosphate dodecahydrate into deionized water, stirring at a constant speed until the sodium phosphate dodecahydrate is dissolved to prepare a solution b for later use, and controlling the dosage ratio of the sodium phosphate dodecahydrate to the deionized water to be 225 g: 1500 mL;
step S12, slowly dripping the solution a into the solution b, heating at 45-60 ℃, stirring at a constant speed, adjusting the pH of the system to 10-12 after dripping is finished, carrying out ultrasonic and stirring at a constant speed for 1h, continuing stirring for 20h after ultrasonic is finished, filtering, and washing with deionized water until the system is neutral to obtain a primary material;
step S13, adding glycidyl methacrylate into a flask filled with deionized water, vacuumizing, introducing nitrogen, heating to 65-70 ℃, uniformly stirring, adding potassium persulfate, preserving heat and reacting for 8 hours, cooling to room temperature, adding anhydrous ethylenediamine, heating to 80 ℃, preserving heat and reacting for 20 hours to obtain a crude product, and washing with anhydrous ethanol and deionized water for three times to obtain a carrier;
and step S14, adding the carrier into deionized water, stirring at a constant speed for 15min, then sequentially adding a silver nitrate solution with the mass fraction of 20%, heating at 125 ℃, continuing stirring for 5min, adding polyvinylpyrrolidone and absolute ethyl alcohol, stirring at a constant speed for 30min, transferring to a sterilization pot, carrying out heat preservation sterilization at the temperature of 130 ℃ and under the pressure of 0.25MPa for 1h, then cooling, adding the primary material, stirring at a high speed for 4h, and then washing with absolute ethyl alcohol for 3 times to obtain the antibacterial composite material.
3. The method of manufacturing a thin polyurethane medical glove according to claim 2, wherein: in step S12, the volume ratio of solution a to solution b is controlled to 1: 1.5.
4. The method of manufacturing a thin polyurethane medical glove according to claim 2, wherein: in step S13, the volume ratio of the glycidyl methacrylate to the deionized water is controlled to be 1: 20, the amount of the anhydrous ethylenediamine is three times of the volume of the glycidyl methacrylate, and the amount of the potassium persulfate is 1-1.8% of the weight of the glycidyl methacrylate.
5. The method of manufacturing a thin polyurethane medical glove according to claim 2, wherein: in the step S14, the dosage ratio of the carrier, the silver nitrate solution, the polyvinylpyrrolidone, the absolute ethyl alcohol, the deionized water and the primary material is controlled to be 10 g: 1-2.5 g: 3 mL: 10 mL: 35-50 g.
6. The method of manufacturing a thin polyurethane medical glove according to claim 1, wherein: the surfactant is any one of sodium dodecyl sulfate and sodium dodecyl sulfate.
7. The method of manufacturing a thin polyurethane medical glove according to claim 1, wherein: the drying temperature in the step S3 is 90-100 ℃, and the drying time is 4 h.
CN202111361942.9A 2021-11-17 2021-11-17 Preparation method of thin polyurethane medical gloves Pending CN113881074A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111361942.9A CN113881074A (en) 2021-11-17 2021-11-17 Preparation method of thin polyurethane medical gloves

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111361942.9A CN113881074A (en) 2021-11-17 2021-11-17 Preparation method of thin polyurethane medical gloves

Publications (1)

Publication Number Publication Date
CN113881074A true CN113881074A (en) 2022-01-04

Family

ID=79017826

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111361942.9A Pending CN113881074A (en) 2021-11-17 2021-11-17 Preparation method of thin polyurethane medical gloves

Country Status (1)

Country Link
CN (1) CN113881074A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114539571A (en) * 2022-02-23 2022-05-27 翔源手套泗阳有限公司 Raw material of antibacterial rubber gloves and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680495A (en) * 2018-12-27 2019-04-26 中广核达胜加速器技术有限公司 A kind of preparation method and antibacterial fabric of nano particle antibacterial fabric
CN112812261A (en) * 2020-12-30 2021-05-18 广东金发科技有限公司 Waterborne polyurethane emulsion, nitrile rubber-polyurethane composite glove and preparation method thereof
CN113121983A (en) * 2021-04-27 2021-07-16 南京瑞润新材料科技有限公司 High-elasticity medical polyurethane glove and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680495A (en) * 2018-12-27 2019-04-26 中广核达胜加速器技术有限公司 A kind of preparation method and antibacterial fabric of nano particle antibacterial fabric
CN112812261A (en) * 2020-12-30 2021-05-18 广东金发科技有限公司 Waterborne polyurethane emulsion, nitrile rubber-polyurethane composite glove and preparation method thereof
CN113121983A (en) * 2021-04-27 2021-07-16 南京瑞润新材料科技有限公司 High-elasticity medical polyurethane glove and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
吕国玉: ""载银羟基磷灰石抗菌织物的研究"" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114539571A (en) * 2022-02-23 2022-05-27 翔源手套泗阳有限公司 Raw material of antibacterial rubber gloves and preparation method thereof
CN114539571B (en) * 2022-02-23 2024-05-10 泗阳翔源医疗科技有限公司 Antibacterial rubber glove raw material and preparation method thereof

Similar Documents

Publication Publication Date Title
CN105238056B (en) A kind of preparation method of antibacterial high temperature silicone rubber
CN105238057B (en) A kind of preparation method of antibacterial silicon rubber
CN102675651B (en) Preparation method of chitosan hydrogel for antiseptic dressing
JP2017165760A (en) Antimicrobial biguanide metal complexes
CN113881074A (en) Preparation method of thin polyurethane medical gloves
CN103668955B (en) Padding-process antibacterial polyester fabric and preparation method thereof
CN103768643B (en) A kind of silver ion alginate sustained-release antibacterial gel and preparation method thereof
CN113773525B (en) Preparation method and application of molybdenum disulfide-loaded nano-silver antibacterial hydrogel
CN106994133A (en) Calcium zinc ion is combined antibacterial alginate slow-release material and preparation method thereof
CN105381500A (en) Functional wound surface repairing material and preparation method thereof
WO2010107482A4 (en) Germicidal composition
CN108904542A (en) The preparation method of Chiral supermolecule hydrogel skin ointments for antibacterial reparation
CN101473850A (en) Antimicrobial liquid of medical gloves and manufacturing method thereof
CN114045577A (en) Silver-containing hydrogel type alginate fiber and preparation method thereof
CN114381083A (en) Antibacterial and antioxidant hydrogel for corneal contact lens and preparation method thereof
CN108929543A (en) Silicon rubber/carrying nano silver ester/modified montmorillonite nano antimicrobial composite material and preparation method thereof
CN106693045A (en) High-bending-strength oral cavity repair material and preparation method thereof
CN116350840A (en) Multifunctional composite hydrogel dressing with antibacterial, antioxidant and self-adhesion functions and preparation method thereof
CN106868327B (en) A kind of preparation method of magnesium alloy smart phone shell of the surface with antibiotic layer
CN113977976B (en) Antibacterial bathroom product and preparation method thereof
CN106719676A (en) One kind can delay the drug-fast bactericidal composition of powdery mildew
CN113897512A (en) Iron-containing antibacterial titanium alloy and preparation method thereof
CN112822606A (en) Earphone earplug and preparation method thereof
CN105597160A (en) Magnesium alloy bone surgical internal fixation and implant material
CN108998744A (en) A kind of preparation method of high-efficiency broad spectrum anti-bacteria stainless steel

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20220104